Q2 2025 Earnings Call Transcript August 14, 2025 First Majestic Silver Corp. misses on earnings expectations. Reported EPS is ...

For more detailed information on SharpLink’s second quarter financial and operational results, please refer to the Quarterly Report on Form 10-Q filed with the U.S. Securities and Exchange Commission ...

Management reiterated the expectation that Elfabrio royalties will exceed $100 million by 2030, based on a projected 15% to 20% market share of the Fabry disease market.

MacroGenics has tapped its chief operating officer to take over as chief executive and join the board. The Rockville. Md., biotech company said Wednesday that Eric Risser will formally succeed Scott ...

This news release for Sagicor Financial Company Ltd. ("Sagicor Financial", "Sagicor" or the "Company") should be read in conjunction with the ...

Good Sunday morning from Seattle . . . Our Online Travel Update for the week ending Friday, August 8, 2025, is below. For several weeks now, we’ve ...

Net loss attributable to American Shared Hospital Services for Q2 2025 was $280,000 or $0.04 per share, compared to net ...

Company reports $12.7 million in revenue in Q2'25, consisting primarily of $4.5 million in YCANTH® revenue, net, reflecting sequential growth of 32.5% over Q1'25 and $8.0 million in milestone revenue ...

Nigeria’s internet usage has reached 142.16 million active subscriptions, with monthly data consumption nearly doubling in ...

Detailed price information for Verrica Pharmaceuticals Inc (VRCA-Q) from The Globe and Mail including charting and trades.

Company reports Q2 2025 AUCATZYL® net product revenue of $20.9 million and $29.9 for the first six months of 2025Company recently received conditional marketing authorization from U.K. Medicines and ...

Company reports Q2 2025 AUCATZYL® net product revenue of $20.9 million and $29.9 for the first six months of 2025Company recently received conditional marketing authorization from U.K. Medicines and ...